America's Top Tradeshow Directory | Events In America
Facebook Linked In Twitter Videos

Paid membership required to see this information

Government and Industry Leaders Discuss Funding and Partnership Opportunities

  • Antimicrobial resistance global overview: partnership, funding and investment opportunities
  • Strategies to combat bioterror threats and emerging infectious diseases: vaccine developments and funding availability
  • Advancing medical countermeasures capabilities and infrastructure to protect public health: future outlook

Featured Speakers:

  • Michael G. Kurilla, MD-Ph.D., NATIONAL INSTITUTES OF HEALTH
  • COL Russell Coleman, JOINT PROGRAM EXECUTIVE OFFICE CHEMICAL AND BIOLOGICAL DEFENSE
  • Erin Reichert, Ph.D., DEFENSE THREAT REDUCTION AGENCY
  • Jean B. Patel, Ph.D., D(ABMM), CENTERS FOR DISEASE CONTROL AND PREVENTION
  • Joseph Larsen, Ph.D., BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY
  • Jane M. Knisely, Ph.D., NATIONAL INSTITUTE OF HEALTH
  • Mark Feinberg, MD, Ph.D., MERCK VACCINES
  • Monique K. Mansoura, Ph.D., MBA, NOVARTIS VACCINES
  • David W. Vaughn, MD, MPH, GSK VACCINES


In recent years, US government focus on national security threats posed by public health issues has broadened beyond bioterrorism to include antimicrobial resistant infections and emerging infectious diseases such as Ebola, Chagas, Dengue, and Chikungunya. Recent actions such as the issuance of the PCAST report and the approval of $5.4 billion in new funding to combat Ebola have supplemented existing biodefense opportunities for funding and partnership. In addition, new non-US initiatives, policies and programs have been implemented to combat these threats.

In response BARDA, DTRA, NIH, CDC, JPEO-CBD and the FDA are shifting their priorities to include emerging infectious diseases and AMR. Some of these potentially paradigm shifting approaches include driving technological innovations that will have broad applications to other commercial markets.

How will existing and new biodefense and emerging infectious disease funding be distributed? How will AMR be included in funding opportunities? What are the opportunities for public-private and private partnership? Where are the most lucrative investment opportunities? Where is the market heading?

At the 13th Annual Vaccine + Therapeutics 2015 Summit, scheduled for June 2-4, 2015, government, private company and other stakeholders from the US and the rest of the world will discuss funding and partnership opportunities available in the war against bioterrorism, infectious disease threats and antimicrobial resistance. Year after year, the conference brings together the public health and national security agencies, biotech and pharmaceutical industries, the academic and not-for-profit infectious diseases and CBRN communities to explore strategies for dealing with various challenges, share perspectives, and establish collaboration to further the development of needed medical countermeasures.

Use this code to Avail 10% DISCOUNT: 1552SOCIAL10

- - CLICK HERE FOR MORE INFORMATION OR TO REGISTER - -

If the Infocast's 13th Annual Vaccines + Therapeutics Summit 2015 is important to your business, act now and make the appropriate connections. See the contact information below.

All information in Events In America is deemed to be accurate at the time we add it, and we take steps to verify all details and update our records when new information is provided, but as people, events and circumstances change, we caution users to independently confirm all information. EventsInAmerica.com and Events In America LLC make no guarantee of accuracy and assume no liability for inaccurate information.

Website: http://bit.ly/1bH1h9p...
Conference/Event Dates: 06/02/2015 - 06/04/2015
Expo/Exhibit Dates: 06/02/2015 - 06/04/2015
Classification: B2B
Primary Industry: Safety
Other Industries: Business, Clinical Pharmacology, Federal Government, Government, Professional Healthcare, Safety
Estimated Attendance: 200
Cost to Attend: $1395.00
Audience: public health and national security agencies, biotech and pharmaceutical industries, the academic and not-for-profit infectious diseases and CBRN communities
Venue: The Almas Temple Club
Venue Phone: (202) 898-1688
Venue Type: Indoor - Hotel
Show Owner:Information Forecast Inc
Sponsorship: Yes

Booth Size Booth Cost   Available Amenities
Call for information.   Electricity: n/a
  Water: n/a
  Generator: n/a
  Marketing Vehicles Allowed: Call
Other Booth Sizes Available: n/a

Advance Networking

How do I show up here?
 

Personal Notes

Add a note here, it is only visible by you.

New Search Contact This Event
Infocast's 13th Annual Vaccines + Therapeutics Summit 2015

exhibitor lists